Frontiers in Medical Science Research, 2026, 8(5); doi: 10.25236/FMSR.2026.080502.
Yuehan Zhu1,2, Ziqi Chen1,3, Jiansheng Cai1,2, Tingyu Mai1,2, Chaofan Xie1,2, Bin Wang1,2, You Li1,2
1Department of Environmental Health and Occupational Medicine, School of Public Health, Guilin Medical University, Guilin, 541199, China
2Guangxi Health Commission Key Laboratory of Entire Lifecycle Health and Care (Guilin Medical University), Guilin, 541199, China
3Qinzhou Center for Disease Control and Prevention, Qinzhou, 535000, China
This study aimed to investigate whether the protective effect of 6-shogaol on aging-induced renal injury is associated with autophagy mediated by the PI3K/AKT/FoxO3 signaling pathway. The aging mouse model was established by intraperitoneal injection of D-galactose (D-gal), followed by intragastric administration of 6-shogaol at low, medium and high doses (5, 10, 20 mg/kg body weight). We measured serum creatinine (CRE) and blood urea nitrogen(BUN) levels. We examined renal histopathology and aging status using hematoxylin-eosin (H&E) staining, Masson's trichrome staining, and β-galactosidase staining. We determined superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), and malondialdehyde (MDA) levels in renal tissue. The mRNA expression levels of Beclin1, LC3, Cdkn1a, PI3K, AKT, and FoxO3 were quantified by quantitative real-time PCR (qRT-PCR). We assessed the expression of autophagy marker proteins Beclin1 and LC3B using Immunohistochemistry(IHC). We also evaluated PI3K/AKT/FoxO3 pathway-related protein expression and phosphorylation status. Compared with the control group, the D-gal group displayed reduced organ coefficients(P<0.01), increased serum BUN and CRE levels(P<0.05), severe renal histopathological injury and collagen deposition, accelerated aging phenotypes, decreased SOD and GSH-Px activities(P>0.05), elevated MDA content(P<0.05), together with upregulated mRNA levels of Beclin1, LC3, Cdkn1a, AKT and FoxO3 and enhanced protein expression of the autophagy markers Beclin1 and LC3B(P<0.05), downregulated p-AKT/AKT(P<0.05). When compared with the D-gal model group, 6-shogaol intervention decreased serum BUN and CRE levels in a dose-dependent manner, with the medium-dose group showing the optimal therapeutic effect(P<0.05). Meanwhile, 6-shogaol ameliorated renal histopathological damage, elevated SOD and GSH-Px activities, and lowered MDA content(P<0.01). Furthermore, it downregulated the mRNA levels of LC3, Cdkn1a, PI3K and FoxO3 as well as the protein expression of autophagy-related markers Beclin1 and LC3B(P<0.05), while concurrently increasing the phosphorylation of PI3K/AKT/FoxO3 pathway proteins(P<0.05). Collectively, these findings demonstrate that 6-shogaol can alleviate aging-induced renal injury, and its renoprotective mechanism may involve the inhibition of excessive autophagy via modulating the PI3K/AKT/FoxO3 signaling pathway.
6-Shogaol, D-galactose, Kidney aging, Autophagy
Yuehan Zhu, Ziqi Chen, Jiansheng Cai, Tingyu Mai, Chaofan Xie, Bin Wang, You Li. 6-Shogaol Attenuates Renal Aging Induced by D-galactose via Inhibiting PI3K/AKT/FoxO3 Signaling-mediated Autophagy. Frontiers in Medical Science Research (2026), Vol. 8, Issue 5: 12-22. https://doi.org/10.25236/FMSR.2026.080502.
[1] MA D, ZHOU K, XU J, et al. Industrial structure upgrading, population aging and migration: An empirical study based on Chinese provincial panel data[J]. PloS One, 2023, 18(10): e0291718.
[2] LI H, ZHAI B, SUN J, et al. Antioxidant, Anti-Aging and Organ Protective Effects of Total Saponins from Aralia taibaiensis[J]. Drug Design, Development and Therapy, 2021, 15: 4025-4042.
[3] LI L, LI Y, LUO J, et al. Resveratrol, a novel inhibitor of GLUT9, ameliorates liver and kidney injuries in a D-galactose-induced ageing mouse model via the regulation of uric acid metabolism[J]. Food & Function, 2021, 12(18): 8274-8287.
[4] FOREMAN K J, MARQUEZ N, Dolgert A, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories[J]. Lancet, 2018, 392(10159): 2052-2090.
[5] LI Y, LERMAN L O. Cellular Senescence: A New Player in Kidney Injury[J]. Hypertension, 2020, 76(4): 1069-1075.
[6] ATTALLAH K A, EL-DESSOUKI A M, ABD-ELMAWLA M A, et al. The therapeutic potential of naturally occurring 6-shogaol: an updated comprehensive review[J]. Inflammopharmacology, 2025.
[7] CHOI J G, KIM S Y, JEONG M, et al. Pharmacotherapeutic potential of ginger and its compounds in age-related neurological disorders[J]. Pharmacology & Therapeutics, 2018, 182: 56-69.
[8] ALMATROODI S A, ALNUQAYDAN A M, BABIKER A Y, et al. 6-Gingerol, a Bioactive Compound of Ginger Attenuates Renal Damage in Streptozotocin-Induced Diabetic Rats by Regulating the Oxidative Stress and Inflammation[J]. Pharmaceutics, 2021, 13(3): 317.
[9] ZHU H, YANG D, DU P, et al. 6-shogaol improves the cognitive and memory declines of natural aging mice by modulating butyrate-producing microbiota and intestinal barrier[J]. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, 2025, 148: 157381.
[10] FAN W, MORINAGA H, KIM J J, et al. FoxO1 regulates Tlr4 inflammatory pathway signalling in macrophages[J]. The EMBO journal, 2010, 29(24): 4223-4236.
[11] CHEN X, LIU W, XIAO J, et al. FOXO3a accumulation and activation accelerate oxidative stress-induced podocyte injury[J]. FASEB journal: official publication of the Federation of American Societies for Experimental Biology, 2020, 34(10): 13300-13316.
[12] JIN L, SHEN N, WEN X, et al. CTLA4-Ig protects tacrolimus-induced oxidative stress via inhibiting the AKT/FOXO3 signaling pathway in rats[J]. The Korean Journal of Internal Medicine, 2023, 38(3): 393-405.
[13] LI L, ZVITI R, HA C, et al. Forkhead box O3 (FoxO3) regulates kidney tubular autophagy following urinary tract obstruction[J]. The Journal of Biological Chemistry, 2017, 292(33): 13774-13783.
[14] MINAMI S, YAMAMOTO T, YAMAMOTO-IMOTO H, et al. Autophagy and kidney aging[J]. Progress in Biophysics and Molecular Biology, 2023, 179: 10-15.
[15] XIAO Q. Cinnamaldehyde attenuates kidney senescence and injury through PI3K/Akt pathway-mediated autophagy via downregulating miR-155[J]. Renal Failure, 2022, 44(1): 601-614.
[16] DONG D, CAI G Y, NING Y C, et al. Alleviation of senescence and epithelial-mesenchymal transition in aging kidney by short-term caloric restriction and caloric restriction mimetics via modulation of AMPK/mTOR signaling[J]. Oncotarget, 2017, 8(10): 16109-16121.
[17] KUME S, UZU T, HORIIKE K, et al. Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney[J]. The Journal of Clinical Investigation, 2010, 120(4): 1043-1055.
[18] XIE Y, SHI X, SHENG K, et al. PI3K/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia (Review)[J]. Molecular Medicine Reports, 2019, 19(2): 783-791.
[19] SPANGLE J M, ROBERTS T M, ZHAO J J. The emerging role of PI3K/AKT-mediated epigenetic regulation in cancer[J]. Biochimica Et Biophysica Acta. Reviews on Cancer, 2017, 1868(1): 123-131.
[20] SHA J Y, LI J H, ZHOU Y D, et al. The p53/p21/p16 and PI3K/Akt signaling pathways are involved in the ameliorative effects of maltol on D-galactose-induced liver and kidney aging and injury[J]. Phytotherapy research: PTR, 2021, 35(8): 4411-4424.
[21] ZHANG X, WANG L, PENG L, et al. Dihydromyricetin protects HUVECs of oxidative damage induced by sodium nitroprusside through activating PI3K/Akt/FoxO3a signalling pathway[J]. Journal of Cellular and Molecular Medicine, 2019, 23(7): 4829-4838.
[22] CUI H, TANG D, GARSIDE G B, et al. Wnt Signaling Mediates the Aging-Induced Differentiation Impairment of Intestinal Stem Cells[J]. Stem Cell Reviews and Reports, 2019, 15(3): 448-455.
[23] ZHANG D Y, WANG H J, TAN Y Z. Wnt/β-catenin signaling induces the aging of mesenchymal stem cells through the DNA damage response and the p53/p21 pathway[J]. PloS One, 2011, 6(6): e21397.
[24] REN B, WANG M, HAO D, et al. Dendrobium officinale extract alleviates aging-induced kidney injury by inhibiting oxidative stress via the PI3K/Akt/Nrf2/HO-1 pathway[J]. Journal of Ethnopharmacology, 2025, 352: 120156.
[25] XU Y, BAI L, CHEN X, et al. 6-Shogaol ameliorates diabetic nephropathy through anti-inflammatory, hyperlipidemic, anti-oxidative activity in db/db mice[J]. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 2018, 97: 633-641.
[26] SHI J, XU Y, ZHANG K, et al. Fucoidan Oligosaccharide Supplementation Relieved Kidney Injury and Modulated Intestinal Homeostasis in D-Galactose-Exposed Rats[J]. Nutrients, 2025, 17(2): 325.
[27] TBAHRITI H F, MESSAOUDI A, KADDOUS A, et al. The degree of chronic renal failure is associated with the rate of pro-inflammatory cytokines, hyperhomocysteinemia and with oxidative stress[J]. Annales De Cardiologie Et D’angeiologie, 2014, 63(3): 135-139.
[28] SOLANKI M H, CHATTERJEE P K, GUPTA M, et al. Magnesium protects against cisplatin-induced acute kidney injury by regulating platinum accumulation[J]. American Journal of Physiology. Renal Physiology, 2014, 307(4): F369-384.
[29] SATO-HORIGUCHI C, OGAWA D, WADA J, et al. Telmisartan attenuates diabetic nephropathy by suppressing oxidative stress in db/db mice[J]. Nephron. Experimental Nephrology, 2012, 121(3-4): e97-e108.
[30] GWON M G, GU H, LEEM J, et al. Protective Effects of 6-Shogaol, an Active Compound of Ginger, in a Murine Model of Cisplatin-Induced Acute Kidney Injury[J]. Molecules, 2021, 26(19): 5931.
[31] CHEN C Y, KAO C L, LIU C M. The Cancer Prevention, Anti-Inflammatory and Anti-Oxidation of Bioactive Phytochemicals Targeting the TLR4 Signaling Pathway[J]. International Journal of Molecular Sciences, 2018, 19(9): 2729.
[32] BISCHOFF-KONT I, FÜRST R. Benefits of Ginger and Its Constituent 6-Shogaol in Inhibiting Inflammatory Processes[J]. Pharmaceuticals, 2021, 14(6): 571.
[33] SRIVASTAVA A, TOMAR B, SHARMA D, et al. Mitochondrial dysfunction and oxidative stress: Role in chronic kidney disease[J]. Life Sciences, 2023, 319: 121432.
[34] OU H L, SCHUMACHER B. DNA damage responses and p53 in the aging process[J]. Blood, 2018, 131(5): 488-495.